kubby cannabis patent

[vapor]

http://www.pot.tv/video/2014/01/06/KUBBY-TV-67-Kubby-Sells-Med-MJ-Patent-Rights-1-Million


"
KUBBY TV #67: Kubby Sells Med MJ Patent Rights for $1 Million
Monday, January 6 2014

Steve Kubby has just sold his medical marijuana patent that is pending for $1 million and has been hired to be CEO of Cannabis Sativa Inc.

Cannabis Sativa (CBDS) has signed an agreement to purchase the patent pending for what is being called af super potent medicinal cannabis strain. The agreement gives CBDS an option to purchase KUSH Inc., the owner of the patent pending, for an additional $1 million. Kubby owns KUSH.

The strain, called CTA, has been under review by the U.S. Patent Office since April 30, 2010.

"We are very pleased to announce our acquisition of what we believe will be the world's first patented cannabis plant," Cannabis Sativa President David Tobias said in a press release. "(Kubby) played a key role in raising the money to put Prop. 215, California's historic 1996 medical marijuana voter initiative, on the ballot. He is a pioneer and respected leader in the cannabis community and brings a wealth of experience and contacts to CBDS."

The KUSH management team, which includes cannabis expert Ed Rosenthal, former New Mexico Gov. Gary Johnson and former Sen. Mike Gravel, D-Alaska, is expected to join CBDS."


what are folks thinking about this, i would like more details of the CTA strain. The value of terps, well i think many of us have known this for some time. Interesting... thoughts? I know my fav plants are oldies peace

 

[CosmicGiggle]

Very interesting, what does 'CTA' stand for, is it a strain name and did Kubby breed it???

 

[vapor]

Yes a strain with massive terps or different terps, maybe a landrace from Ecuador mixed with?, not quite sure i need to learn more...

 

[stickshift]

Any truth in it being CTS from Fed? it's an Ecuador sat in the CTA isn't it?

https://www.icmag.com/ic/showthread.php?t=277307

Anyone got a link to the patent?

Is this why the strain was only about for a short while? Kubby has def liked this varietal I think I remember in a interview he named it as his fav and that it had no ceiling it certainly fits the bill..

http://www.mrnice.nl/forum/14-indoor/5726-celestial-temple-sativa.html

 

[bigbag]

I would say yes for sure, as Kubby was in exile up here in BC, back when Emery was in his hay day. So he def had access to all of FED's line up, at that time...
here's a description; " our Celestial Temple Sativa from Equador, grows a bamboo like stock, with huge, thin, heavily serrated leaves. resin glands are unique, in that they have smaller, shorter heads, but are extremely dense, turning them frosty when ready. any true sativa fan will appreciate this !"

 

[Gert Lush]

I am very curious how anyone can "patent" a cross, especially one that was (by the sounds of it) ripped off from somewhere else.

What exactly is it that is being patented, since a patent relates to a DEMONSTRABLY NEW way of doing something? I know the agri-biz sector is pretty corrupt, but a patent on an F1? Pur-leeze. He should count himself lucky if he can get a trademark for it.

But maybe he's just making a quick buck by treating the wannabe get-rich-quick crew to some smoke and mirrors, in which case, good luck to him...

 

[smilley]

Can't wait to get my hands on it so I can outcross a few hybrids.......

 

[sirius haze]

what a sick world

 

[Morcheeba*]

I am very curious how anyone can "patent" a cross, especially one that was (by the sounds of it) ripped off from somewhere else.

What exactly is it that is being patented, since a patent relates to a DEMONSTRABLY NEW way of doing something? I know the agri-biz sector is pretty corrupt, but a patent on an F1? Pur-leeze. He should count himself lucky if he can get a trademark for it.

But maybe he's just making a quick buck by treating the wannabe get-rich-quick crew to some smoke and mirrors, in which case, good luck to him...

when in doubt Educate yourself.


USPTO.gov and look for plant patents.......its not too difficult to find.


well this should motivate some and strike fear in others..........who are you?

it motivates me.

 

[Gert Lush]

Well, i looked it up, here:
http://www.uspto.gov/web/offices/pac/plant/#1

And as far as I can tell a patent only applies to a plant propagated asexually, i.e. for cannabis a clone, effectively.

So, basically, it seems these muppets are trying to patent a keeper plant of theirs! Good luck to them, and excuse those of us who think the whole thing is beyond laughable.... certainly neither terrifying nor motivating.

Fuckin' clowns.

 

[Morcheeba*]

^^^^sorry for coming across like an ass......I just like going to the source and im still trying to wrap my head around the implication of patented strain's and as Cannabis prohibition ends it will be treated like every other commodity where profits are protected.

 

[Gert Lush]

^^^^sorry for coming across like an ass......

No problem, buddy, sorry if I sounded like I over-reacted!

I have no issue with people making money legitimately from weed, that's a part of legalisation, too.

However, if the law as it stands (assuming I understood it correctly) allows any idiot to patent any ("unique", ha-ha) clone they come across, I can see a real circus ahead!

We are a greedy and horrible lot
If, when we find a beneficial clone, instead of looking to see how we can trace its genetics and make more and better stuff from it, we sit on it, get a patent ffs, and go "it's mine, it's mine, it's mine", that is stiffling the benefits, not spreading them.

There are plenty of legal, yet illegitimate ways of seeking a profit.

 

[trichrider]

i'm in tune with gert.

investors...now with terpenoids.

 

[Charles-scott]

My Wife and I visited with Kubbies when they were n BC he was hungry for pure Sativa's he had the FED CTS , we gave him a few cuttings of the Acapulco gold we used in Apple pie and seeds from the acapulco gold x nepalese .

For the most part there rooms were full of Jamaican sugar back in the day .

Charles

 

[bigbag]

Jamaican Sugar would explain why Kubby used to chain smoke joints...hoping to maybe catch a buzz ! ya mon

 

[Pantagruelion]

The French have patented cannabis(hemp) strains so he's not the first. Once a strain is patented what stops the patent holder from owning all the identical genes in other non related strains? Cannabis has lots more genetic similarities than differences.

 

[Orrie]

Shit got real as of last December with the first cannabis plant patent-



Cannabis Sativa, Inc. Awarded US Patent for “Ecuadorian Sativa” Cannabis Plant (aka CTA)
08
On December 21, 2016In Company News, Press ReleaseTags Cannabis, cannabis sativa, cannabis sativa inc, CBDS, CTA, ecuadorian sativa, OTCQB:CBDS, patent

Cannabis Sativa, Inc. Awarded US Patent for Ecuadorian Sativa Cannabis Plant (aka CTA)



MESQUITE, NV / ACCESSWIRE / December 21, 2016 / Cannabis Sativa, Inc. (OTCQB: CBDS) announced that on December 20, 2016, the company’s subsidiary was awarded Patent PP27,475 for a Cannabis Plant named Ecuadorian Sativa and deemed “CTA”.

Equadorian Sativa has been shown in laboratory testing by Steephill Labs to have a Limonene level that is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets Equadorian Sativa apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.

The objective of the breeding, which produced this novel plant strain, was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and (c) increased food consumption.

Anecdotally, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that Ecuadorian Sativa has many medical qualities that make it an important tool to maintain health and deal with illness.

“Our patience is now rewarded with the issuance of Patent PP27,475”. “This patent will open up new areas for research and opportunities for CBDS”, said CEO Mike Gravel.

This plant was derived from a female said to be of a strain called colloquially, “Celestial Temple Sativa” an individual grown in Ecuador that as a solitary plant reached a height of 23 feet. The male parent is said to have been of a strain known colloquially as “Island Sweet Skunk”.

The Company’s President David Tobias said, ”This is a major accomplishment and is a tribute to the foresight and perseverance of management to solidify Cannabis Sativa’s contribution to the maturing Cannabis industry.

Forward-Looking Statements:

This press release contains “forward-looking statements.” Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Underlying assumptions include without limitation, the ongoing enactment of legislation favorable to the production of and the commercialization of cannabis products and the Company’s success in capitalizing on that legislation. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.



Contact Information:

Investor Relations
Mesquite, NV 89027
702-345-4074
http://www.cannabissativainc.com

SOURCE: Cannabis Sativa Inc.

Search for 'Ecuadorian Sativa'
should lead you to the patent

http://patft.uspto.gov/netacgi/nph-...=50&co1=AND&d=PTXT&s1="ecuadorian+sativa"&OS=

 

[Orrie]

Heres the patent-








United States Patent PP27,475
Kubby December 20, 2016
Cannabis plant named `Ecuadorian Sativa`

Abstract

Unique herbaceous annual `Cannabis sativa` female plants, having numerous glandular flowers in a congested and elongated inflorescence, hollow stems a characteristic of the fiber-producing strains of `Cannabis sativa ssp. sativa` but absent in strains of `Cannabis sativa ssp. indica.` The plants are intoxicating, characteristic of `Cannabis sativa, ssp. indica`, but absent in subspecies sativa. The new strain has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and show hypotensive effects. Morphologically, the plants have a few branched hairs on the stem that are not characteristic of the species, but are ordinary in most other respects.
Inventors: Kubby; Steven Wynn (South Lake Tahoe, CA)
Applicant:
Name City State Country Type

Kubby; Steven Wynn
South Lake Tahoe
CA
US
Assignee: KUBBY PATENT AND LICENSES, LIMITED LIABILITY COMPANY (Burnet, TX)
Family ID: 57322230
Appl. No.: 12/661,271
Filed: March 13, 2010

Current U.S. Class: PLT/263.1
Current CPC Class: A01H 5/00 (20130101)
Current International Class: A01H 5/00 (20060101)
Field of Search: ;PLT/263.1

Other References

Forapani et al. Comparison of Hemp Varieties Using Random Amplified Polymorphic DNA Markers. Crop Science 41:1682-1689 (2001). cited by examiner .
Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products.http://www.unodc.org/documents/scientific/ST-NAR-40-Ebo- ok.pdf 2009. cited by examiner.

Primary Examiner: Para; Annette
Attorney, Agent or Firm: Jacobson Holman, PLLC.
Claims


It is claimed:

1. A new and distinct cultivar of `Cannabis` plant, as shown and described.
Description


The Cannabis plant named `Ecuadorian Sativa` having a laboratory name of `CTS-A` a variety of a cross between `Cannabis sativa; ssp. Sativa` and `Cannabis sativa ssp. Indica (Lam.)`.

BACKGROUND OF THE INVENTION

This invention relates to a novel hybrid of a cross between individuals thought to be of the two subspecies of `Cannabis sativa L.`, `Cannabis sativa; ssp. sativa` and `Cannabis sativa ssp. Indica`.

HISTORICAL NOTE

Human cultivation history of Cannabis dates back 8000 years. Schultes, R E. 1970. Random thoughts and queries on the botany of Cannabis. Pages 11-38 in: CRB Joyce, and SH Curry eds., THE BOTANY AND CHEMISTRY OF CANNABIS. J. & A. Churchill. London, England. Hemp cloth recovered in Europe dates back 6000 years. (Small, E, Beckstead, H D, and Chan, A, 29(3) ECONOMIC BOTANY 29(3): 219-232 (1975). The written record of the pharmacologic properties of Cannabis goes back more than 4000 years. Ti, H. 2737 BC. NEI JING SU WEN HUANG TI (Yellow Emperor's Classic on Internal Medicine; referred to without citation in Small et al. 1975 Supra).

The taxonomy and nomenclature of the highly variable genus Cannabis (Emboden, W A, 29(3) ECONOMIC BOTANY 304-310 (1974)); (Small, E and Cronquist, A, 25(4) TAXON 405-435 (1976)); Small E and Cronquist, A 26(1) TAXON 110 (1977)); (Hillig, K W and Mahlberg, P G, 91(6) American Journal of Botany 966-975 (2004)), remains in question. This is in spite of the fact that its formal scientific name, `Cannabis sativa L.`, assigned by Carolus Linneaus (Linnaeus, C, 2 SPECIES PLANTARUM 1027 (1753), Salvius, Stockholm. Facsimile edition, 1957-1959. Ray Society, London, U.K.), is one of the oldest established names in botanical history and is still accepted to this day. Another species in the genus, `Cannabis indica Lam.` was formally named somewhat later (de Lamarck, J B, 1(2) ENCYCLOPEDIE METHODIQUE DE BOTANIQUE, 694-5,(1785)), but is still very old in botanical history.

Three other species names were proposed in the 1800s to distinguish plants with presumably different characteristics (C. macrosperma Stokes, C. chinensis Delile, C gigantean Vilmorin), none of which are accepted today, although the epithet "indica" lives on as a subspecies of C. sativa (`C. sativa ssp. indica Lam.`. Small and Cronquist 1976 Supra).

In the 20th century, two new names were added to the liturgy of proposed `Cannabis species: C. ruderalis` Janischevsky and a hybrid, .times.`C. intersita` Sojak. Small, E, Jui, P Y, and Lefkovitch, L P, 1(1) SYSTEMATIC BOTANY 1(1): 67-84 (1976); Small and Cronquist 1976, Supra. Further, numerous names have been proposed for horticultural variants of `Cannabis` but as of 1976, "very few of these have been validly published as formal taxa under the International Code of Botanical Nomenclature." Small and Cronquist 1976 Supra. Moreover, other recent work continues to focus on higher-order evolutionary relationships of the genus. Cannabis has been variously ascribed as belonging to the mulberry family (Moraceae) (Engler, H G A, Ulmaceae, Moraceae and Urticaceae, pages 59-118 (1889) in: A. Engler and K. Prantl eds., DIE NATURLICHEN PFLANZENFAMILIEN 3(1). W. Engelmann, Leipzig, Germany; Judd, W S, Sanders, R W, and Donoghue, M J, 5 HARVARD PAPERS IN BOTANY 5: 1-51 (1994)); nettle family

(Urticaceae) (Berg, CC, Systematics and phylogeny of the Urticales, pages 193-220, in: P.R. Crane and S. Blackmore eds., EVOLUTION, SYSTEMATIC, AND FOSSIL HISTORY OF THE HAMAMELIDAE, VOL. 2, HIGHER HAMAMELIDAE, Clarendon Press, Oxford, U.K. (1989); Humpries, C J and Blackmore, S, A review of the classification of the Morcaceae, pages 267-277 In: Crane and Blackmore 1989 id.); and most recently in its own family with hops (Humulus), the Cannabaceae, or hemp family. Sytsma, K J, et al, 89(9) AMERICAN JOURNAL OF BOTANY 1531-1546 (2002).). While the work of Small and Cronquist 1976 Supra, seemed to effectively confine the genus to a single species with 2 subspecies (C. sativa s., C. s. indica), each with two varieties (C. s. s. var. sativa, C. s. s. var. spontanea; C. s. i. var. indica, C. s. i. var. Kafiristanica) largely on the basis of chemotaxonomy and interfertility of all forms, more recent work (Systma et al. 2002, Supra), proposes a two-species concept, resurrecting the binomial C. indica Lam. Since Sytsma et al. 2002 provides no key for discriminating between the species, the dichotomous key of Small and Cronquist 1976 Supra, which accounts for all forms in nature, whether wild or domesticated, was used to classify the characteristics of the plants described herein.

BRIEF SUMMARY OF THE INVENTION

The objective of the breeding program which produced the novel plant of this invention was primarily to develop a plant having the following characteristics: (a) medicinal properties that included hypotensive activity; (b) psychoactive properties that motivated and energized, rather than creating lethargy, sleepiness, and increased food consumption.

The biologically active chemicals found in plants, phytochemicals, affect the normal structure or function of the human body and in some cases treat disease. The mechanisms for the medicinal and psychoactive properties of a cannabis plant, like any medicinal herb, are the pharmacologic effects of its phytochemicals and for a medical cannabis plant, the key phytochemicals are cannabinoids and terpenes. Tetrahydrocannabinol, THC, is the primary psychoactive and medicinal cannabinoid and is the result of the decarboxylation of tetrahydrocannabinolic acid (THC-A), its acidic precursor. THC-A, (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6h-be- nzochromene-2-carboxylic acid, is found in the trichomes of the plant and converted into THC, which actually exists in only minute quantities in the living plant, after harvest and drying. Cannabigerol (CBG), Resorcinol, 2-(3,7-dimethyl-2,6-octadienyl)-5-pentyl-, is not considered psychoactive, is known to block the psychoactive effects of THC. and is considered medically active in a variety of conditions. Its precursor, cannabigerolic acid, CBG-A, (E)-3-(3,7-Dimethyl-2,6-octadienyl)-2,4-dihydroxy-6-pentylbenzoic acid, is being studied medically. Cannabichromene, CBC, and cannabidiol, CBD, are both non-psychoactive and end products of CBG metaolism, like THC, that are used medically Cannabichromenic acid; CBC-A, 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-pentyl-chromene-6-carboxylic acid, is acidic cannabichromene.

`Equadorian Sativa` has been shown by laboratory testing by Steephill Labs to contain cannabinoid CBG-A at 2.49 mg/g, tetrahydrocannibidiol THC-A at 139.46 mg/g, THC at 2.24 mg/g and cannabinoid CBC-A at 1.75 mg/g. `Equadorian Sativa` cannabinoid content is dominated by its high content of THC (2.24 mg/g) and THC-A (139.46 mg/g).

Most varieties of high potency cannabis contain large quantities of three specific terpenes as well as various assortments of others. Those three terpenes are Beta-Myrcene, Beta Caryophyllene and Linalool. For instance, the variety CT3 has a profile with a high level of Beta-Myrcene, a moderate amount of Beta Caryophyllene and a small amount of Linalool, and a moderate amount of Limonene. `Equadorian Sativa` has an unusual complement of terpenes. There are small levels of Beta Myrcene, Beta Caryophyllene and Linalool, but the Limonene level is extraordinarily high at a level of 4.53, 10 to 20 times the usual range. This sets `Equadorian Sativa` apart from other varieties in its odor, the effects on mood and mentation and its medical qualities.

Physically, there are indications that its use may prevent some cancers and may cause apoptosis of cancer cells in vivo. There is a good possibility that the high levels of limonene may slow down the build-up of plaque in the arteries and reduce the effect of low-density lipo-proteins on the circulatory system. Indications are that `Equadorian Sativa` has many medical qualities that make it an important tool to maintain health and deal with illness.

The inventor cultivated various strains of `Cannabis sativa` in an effort to create a strain best suited to control his own disorder. This plant was derived from a female said to be of a strain called colloquially, `Celestial Temple Sativa` an individual grown in Ecuador that reached a height of 23 ft (7 m), and was of the typical subspecies, `Cannabis sativa ssp. sativa`. The male parent is said to have been of a strain known colloquially as `island sweet skunk` and reportedly to belonged to the subspecies `Cannabis sativa ssp. indica (Lam.)`. Small and Cronquist 1976 Supra. Neither `Celestial Temple Sativa` nor `island sweet skunk` has been patented in the United States or elsewhere, nor are they the subject of any pending patent applications of which the inventor is aware.

The particular plant disclosed herein was discovered in the area where the inventor was intentionally cross-pollinating and cultivating plants of cross between `Celestial Temple Sativa` and `island sweet skunk` described above using standard Mendelian breeding procedures well known to those of ordinary skill in the art. This resulted in the F1 generation of the inventor's cross, named `Pleadian`. It was in the proximity of plants of the `Pleadian` variety that had become hermaphroditic, in the inventor's garden in Lake Tahoe Calif. that he discovered one female plant that could only be reproduced assexually, by taking cuttings and that plant is the origin of this remarkable new strain. The female plant was discovered in a section of the inventor's hydroponic garden. The plant has been and continues to be assexually reproduced by cutting at the inventor's garden in Lake Tahoe Calif.

Comparison of the Steephill Laboratory terpenoid/cannabinoid profiles of `Equadorian sativa` with other plants with the same parents, `island sweet skunk` and `Celestial Temple Sativa` reveals that this plant, `Equadorian sativa` has a phenotypically unique profile, particular insofar as its levels of limonene. Two plants with the same parents were known by the laboratory names of CTK and CT3 and `Equadorian sativa` was tested by the laboratory name of CTA. Limonene found in `Equadorian sativa`, were 45.35 mg/g while CTK and CT3 were only 2.24 mg/g and 1.03 mg/g respectfully. `Equadorian sativa` was shown to have substantially lower levels of cannabigerolic acid (CBG-A). cannabigerol (CBG) and Beta-Myrcene. `Equadorian sativa` had levels of only 2.49 mg/g of CBG-A while CTK had 6.1 mg/g CBG-A and CT3 had 8.13 mg/g of CBG-A. `Equadorian sativa` had only 0.001 mg/g of CBG while CTK had 0.3 mg/g CBG and CT3 had 0.54 mg/g of CBG. `Equadorian sativa` had only 1.1 mg/g Beta-Myrcene while CTK had 12.01 mg/g Beta-Myrcene and CT3 had 11.44 mg/g Beta-Myrcene.

This data is presented in tabular form in Table 1.

TABLE-US-00001 TABLE 1 Plant CTA CTK CT3 Terpinoid or Cannabinoid mg/g mg/g mg/g CBG-A 2.49 6.1 8.31 CBG 0.001 0.3 0.54 Beta Myrcene 1.1 12.02 11.44 Limonene 45.35 2.24 1.03

Asexual reproduction, colloqually known as "cloning" is a process well known to those of ordinary skill in the art of gardening and includes the following steps:

Step 1: From the female plant whose genetic profile is sought to be exactly reproduced, a 1''- 2'' cutting is taken;

Step 2: The cutting of the desired plant and is placed in a rooting solution that may be water, or a B1 vitamin that is generally the content of a rooting or cloning powder or gel;

Step 3: The cutting and rooting solution are placed into a rooting medium such as rock wool and RAPID ROOTER.RTM. a peat moss product available at hydroponics stores, gardening supply stores, and from many Internet merchants and must be water retaining so that the roots can take water up into the leaves; Step 4: The cutting in rooting solution and rooting medium is placed under a humidity dome that may be an inverted plastic cup or is available in kits 1'-2' long with a clear plastic dome to keep the humidity as high as possible to avoid the leaves drying before the cutting roots to insure viability; Step 5: A a fluorescent light is placed just over the humidity dome that may be a generic work light available at hardware stores; Step 6: One to two times a day, the humidity dome is removed for 30 seconds to insure the exchange of depleted air with fresh air to replenish the CO2. Step 7: After maintaining this cutting in this manner, keeping the rooting medium wet at all times, for 5-14 days until root formation Step 8: The rooted plants are maintained under flourescent high intensity lights in a soil-less medium, with standard hydroponic fertilizers, for 14 weeks; The plant observed and identified in the photographs was cultivated in this manner at a temperature between 76 and 80 degrees Fahrenheit and was 14 weeks of age. The new plant differs from its parents and related cultivars in that it has energizing and motivating psychoactive effects as opposed to the lethargy normally associated with ssp. indica and the instant plant also shows hypotensive effects.

Observation of the all female progeny of the original plant has demonstrated that this new and distinct variety has fulfilled the objectives and that its distinctive characteristics are firmly fixed and hold true from generation to generation vegetatively propagated from the original plant.

BRIEF DESCRIPTION OF THE PHOTOGRAPHS

The accompanying photographs illustrate the overall appearance of the new `Equadorian sativa` plants. These photographs show the colors as true as it is reasonably possible to obtain in reproductions of this type. Colors in the photographs may differ slightly from the color values cited in the detailed botanical description which accurately describe the colors of the new plant.

Sheet 1 `Cannabis CTS-A` shows the flower of the `Equadorian sativa` plant in the midst of leaves from above.

The photograph at the bottom of the Sheet 2, `Cannabis CTS-A` comprises a close-up view of the flowering plant of `Equadorian sativa`;

Sheet 3, `Cannabis CTS-A` comprises a slightly oblique and very close view of the `Equadorian sativa`.

DETAILED BOTANICAL DESCRIPTION

The following is a detailed description of the new cultivar of `Equadorian sativa`. The plant: Type (life form and habit).--Herbaceous tap-rooted annual. Classification.--Cultivars of `Cannabis sativa`, possessing traits of the subspecies, `C. sativa ssp.. indica (Lam.)` When navigating the key of Small and Cronquist, Id., the first couplet separates individuals based on their ability to intoxicate. This cultivated line possesses intoxicating properties, and so the subspecies sativa and its varieties (var. sativa and spontanea) are eliminated from consideration. Within the next couplet distinguishing within the subspecies indica, fruits are required to separate between the varieties (var. indica and var. kafiristanica). No fruits were found on any of the individuals observed, and so discrimination between the varieties is impossible with this key. Nevertheless, cross-section of the stem revealed that the stem is hollow, a characteristic known to occur with the fiber-producing strains of C. sativa ssp. sativa, and thought to be absent from the intoxicating taxa in the genus. As such, these plants appear to be hybrids of the two subspecies of `Cannabis sativa`, e.g., `C. sativa s.` and `C. s. indica`. Origin, form, and growth characteristics: Origin.--Whole Plant Natural Mutation of the F1 cultivar Pleadian. Propagation.--The strain is perpetuated solely by cuttings. Mature habit.--Tap-rooted annual, with extensive fibrous root system, upright and much branched aerial portion of plant. The growth form of all cloned individuals seen (n=10) was highly manipulated by systematic removal of terminal buds, inducing a greater branching habit. Overall size in this form varies in the population from 1.6-1.9 m tall and 0.3-0.4 m across at their widest point. Many petiole scars on stems from systematic removal of large shade leaves. In this habit, these are obviously very vigorous annual herbs. Growth.--Very vigorous annuals herbs. Foliage: Leaves. Arrangement.--Alternate. Form.--Palmately compound, (3) 5-7 (9) linear-lanceolate leaflets with glandular hairs. Size.--Remaining (those still present when plants were observed) shade leaves, whole. Leaf (with petiole).--18-20 cm long; middle (largest) leaflet 10-12 cm long, 2.8 cm wide. Margins.--Coarsely serrate. Color.--Top -- dark green, Pantone PMS 364. Color.--Bottom -- light green, Pantone PMS 377. Veins, bottom.--Pronounced midrib, with straight axial branches at about 45.degree. angle, toward distal end of leaflet. Color.--Light green, Pantone PMS 377. Petiole.--Length: 9-10 cm at maturity. Color.--Light green, Pantone PMS 377 as in the lower leaf surfaces. Stipules.--Sometimes present at base of petiole, 0.5 cm long, bulbous bases, acuminate (tapering concave to apex). Aroma.--Strongly mephitic, with hints of limonene, a cyclic terpene in Pinus ponderosa. Stem: Hollow, large, rugose, punctuate, minutely glandular, ribbed, with ribs running parallel to stem, 2.0-2.5 cm diameter at base. Color.--Bottom -- light green, Pantone PMS 377. A few eglandular branched hairs. Height.--1.5-1.9 m at anthesis following heavy pruning regime in cultivation. Inflorescence: Blooming habit.--Elongated compound cymes or panicles, forming spikes from 0.3-0.5 m in length, densely packed with individual small pistillate flowers subtended by small leaves, these with densely packed capitate glandular trichomes. Flowers: Corolla.--Petals and calyx unified and collectively appressed to and surrounding the ovary. Color.--Light green, Pantone 372. Diameter.--Individual pistillate flowers 2-3 mm, cyme 5-10 cm diameter. Shape.--Urceolate (urn-shaped). Involucral bracts.--Absent, but two highly glandular, urceolate bracteoles enclose the flower. Calyces.--Appressed to the base of the ovary with the corolla as a unified perianth. Color.--Green, Pantone PMS 364. Filaments.--N/A -- no staminate flowers observed. Stigma.--Length 5-7 mm, ca. 1 mm wide at base, tapering to distal end. Densely covered with minute (<1 mm) soft, straight hairs. Color.--Lemony white, Pantone PMS 372, drying slowly to red from apex to base after anthesis. Number.--2. Staminate column.--N/A -- no staminate flowers observed. Fruit.--An achene in this genus; however, no fruits were seen as all pistillate flowers were sterile. Pollen.--N/A -- no staminate flowers observed. Color: N/A -- no staminate flowers observed. Petalage.--The plant is essentially without petals (apetalous); these fused and appressed to the base of the ovary with the calyx as the perianth. Flowers: Pedicel.--flowers are essentially sessile (attached directly to the stem), and as such have no pedicel. The color chart referenced is standard hexadecimal Web Pantone Color Chart well known to those of ordinary skill in Internet web site design. General characteristics and culture: Blooming period.--Cuttings after rooting will bloom in 9-11 weeks when <12 hrs light applied to induce flowering. Hardiness.--Probably fairly hardy; however, hardiness in nature unknown as this plant has only been cultivated in controlled conditions. Breaking action.--Stems are fibrous, strong, and flexible; highly resistant to breakage. Rooting.-->95% success rate with cuttings using CLONEX.RTM. a vitamin B1 rooting compound. Growth regulator.--No growth regulators or other hormones used in cultivation. Shipping tolerance.--Not applicable. This plant has never been shipped and is not intended for live shipment or household cultivation.



http://patft.uspto.gov/netacgi/nph-P...+sativa"&OS=

 

[shaggyballs]

Patented: A new and distinct cultivar of `Cannabis` plant, as shown and described.

So can any new and distinct cultivar be patented?
Now should we all rush out to patent our new cultivar?
What is the legal definition of a distinct cultivar?
How many new distinct cultivar are already under a patent?

This is going to be very ugly very soon!
Uggg!

 

[djonkoman]

if you want to know the legal meaning of distinct, look up UPOV and plant breeder rights.

usually protection of plant varieties is done trough plant breeder rights and not patents, but in the US patents can be used to(in europe you can't patent a plant cultivar, it has to go trough plant breeder rights instead). plant breeder rights have the breeder's exemption, which allow anyone to use any existing protected variety for breedingpurposes.

to qualify, a variety has to be distinct, uniform and stable.

I think most current strains wouldn't qualify based on the uniform and stable requirements. and since they're already on the market, they can't be pattented or claimed for plant breeder's rights, it's already state of the art.